Zotefoams plc (LON:ZTF - Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 302.66 ($4.07) and traded as high as GBX 418 ($5.62). Zotefoams shares last traded at GBX 414 ($5.56), with a volume of 59,920 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank restated a "buy" rating and set a GBX 540 target price on shares of Zotefoams in a research report on Tuesday, August 26th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of GBX 540.
Read Our Latest Report on Zotefoams
Zotefoams Stock Down 0.3%
The company has a debt-to-equity ratio of 42.07, a quick ratio of 0.67 and a current ratio of 1.30. The firm has a market capitalization of £201.10 million, a PE ratio of -7,291.61, a PEG ratio of 0.66 and a beta of 1.40. The company's 50 day simple moving average is GBX 352.33 and its 200-day simple moving average is GBX 302.66.
Zotefoams (LON:ZTF - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported GBX 19.99 earnings per share (EPS) for the quarter. Zotefoams had a net margin of 7.45% and a return on equity of 8.42%.
About Zotefoams
(
Get Free Report)
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zotefoams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zotefoams wasn't on the list.
While Zotefoams currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.